<DOC>
	<DOC>NCT01246583</DOC>
	<brief_summary>The study is being conducted to see whether CP-690,550 ointment has potential as a safe and effective treatment for adult patients with mild to moderate chronic plaque psoriasis.</brief_summary>
	<brief_title>CP-690-550 Ointment For Chronic Plaque Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Tofacitinib</mesh_term>
	<criteria>Mild to moderate chronic plaque psoriasis (psoriasis vulgaris), with the duration of at least 6 months; A target plaque of at least 9 sq. cm. Demonstrates "rebound" or "flare" of chronic plaque psoriasis; Non plaque form of psoriasis; Currently have or history of psoriatic arthritis; Current drug induced psoriasis; Currently on systemic therapy or was on systemic therapy for psoriasis within the previous 6 months; Currently on phototherapy for psoriasis or was on phototherapy within the previous 3 months</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Multi Site</keyword>
	<keyword>Randomized</keyword>
	<keyword>Placebo Controlled</keyword>
	<keyword>Double Blind</keyword>
	<keyword>Parallel Group</keyword>
	<keyword>chronic plaque psoriasis</keyword>
	<keyword>topical treatment</keyword>
	<keyword>skin diseases</keyword>
	<keyword>papulosquamous</keyword>
</DOC>